Literature DB >> 12750175

Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes.

Renato Zambello1, Michela Falco, Mariella Della Chiesa, Livio Trentin, Davide Carollo, Roberta Castriconi, Giovanna Cannas, Simona Carlomagno, Anna Cabrelle, Thierry Lamy, Carlo Agostini, Alessandro Moretta, Gianpietro Semenzato, Massimo Vitale.   

Abstract

Using monoclonal antibodies (mAbs) specific for different natural killer (NK) receptors, we studied the lymphocyte population from 18 patients with NK-type lymphoproliferative disease of granular lymphocytes (LDGL). The analysis of both resting and cultured NK cell populations demonstrated that these patients are frequently characterized by NK cells displaying a homogeneous staining with given anti-killer Ig-like receptor (anti-KIR) mAb (11 of 18 patients). In most patients NK cells were characterized by the CD94/NKG2A+ phenotype, whereas only a minor fraction of the cases expressed CD94/NKG2C. In 7 of these patients we could also assess the function of the various NK receptors. Remarkably those KIR molecules that, in each patient, homogeneously marked the NK cell expansion were found to display an activating function as determined by cross-linking with specific anti-KIR mAb. The KIR genotype analysis performed in 13 of 18 cases revealed that in NK-type LDGL certain activating KIRs, as well as certain infrequent KIR genotypes, were detected with higher frequencies as compared to previously analyzed healthy donors. Moreover, most KIR genotypes included multiple genes coding for activating KIRs. The analysis of non-HLA-specific triggering receptors indicated that the natural cytotoxicity receptors (NKp46, NKp30) were expressed at significantly low levels in freshly drawn NK cells from most patients analyzed. However, in most instances the expression of NKp46 and NKp30 could be up-regulated on culture in interleukin 2. Our data indicate that in NK-LDGL the expanded subset is frequently characterized by the expression of a given activating KIR, suggesting a direct role for these molecules in the pathogenetic mechanisms of this disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750175     DOI: 10.1182/blood-2002-12-3898

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  Gaining insights into chronic natural killer cell leukemias through extensive characterization of an individual case.

Authors:  William G Morice; Jadee Neff; John Kwan
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

Review 2.  Natural killer cells in human autoimmune diseases.

Authors:  Nicolas Schleinitz; Frédéric Vély; Jean-Robert Harlé; Eric Vivier
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

3.  Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30).

Authors:  E Mavoungou; M K Bouyou-Akotet; P G Kremsner
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

4.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

5.  Distribution of several activating and inhibitory receptors on CD3-CD16+ NK cells and their correlation with NK cell function in healthy individuals.

Authors:  Gordana Konjević; Katarina Mirjacić Martinović; Ana Vuletić; Vladimir Jurisić; Ivan Spuzić
Journal:  J Membr Biol       Date:  2009-08-27       Impact factor: 1.843

6.  Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches.

Authors:  Renato Zambello; Gianpietro Semenzato
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

7.  Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.

Authors:  E Poullot; R Zambello; F Leblanc; B Bareau; E De March; M Roussel; M L Boulland; R Houot; A Renault; T Fest; G Semenzato; T Loughran; T Lamy
Journal:  Ann Oncol       Date:  2014-08-05       Impact factor: 32.976

8.  Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway.

Authors:  Jun Yang; Xin Liu; Susan B Nyland; Ranran Zhang; Lindsay K Ryland; Kathleen Broeg; Kendall Thomas Baab; Nancy Ruth Jarbadan; Rosalyn Irby; Thomas P Loughran
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

9.  Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity.

Authors:  Mirna Balsamo; Francesca Scordamaglia; Gabriella Pietra; Claudia Manzini; Claudia Cantoni; Monica Boitano; Paola Queirolo; William Vermi; Fabio Facchetti; Alessandro Moretta; Lorenzo Moretta; Maria Cristina Mingari; Massimo Vitale
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-23       Impact factor: 11.205

10.  Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling.

Authors:  P K Epling-Burnette; Lubomir Sokol; Xianhong Chen; Fanqi Bai; Junmin Zhou; Michelle A Blaskovich; JianXiang Zou; Jeffrey S Painter; Todd D Edwards; Lynn Moscinski; Jeffrey A Yoder; Julie Y Djeu; Said Sebti; Thomas P Loughran; Sheng Wei
Journal:  Blood       Date:  2008-09-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.